An immune globulin intravenous (human), 10% liquid privigen: for the treatment of primary immunodeficiency diseases
- PMID: 19572041
- PMCID: PMC2697917
An immune globulin intravenous (human), 10% liquid privigen: for the treatment of primary immunodeficiency diseases
Figures
Similar articles
-
Safety of L-proline as a stabilizer for immunoglobulin products.Expert Rev Clin Immunol. 2012 Feb;8(2):169-78. doi: 10.1586/eci.11.97. Expert Rev Clin Immunol. 2012. PMID: 22288455 Review.
-
A 10% liquid immunoglobulin preparation for intravenous use (Privigen®) in paediatric patients with primary immunodeficiencies and hypersensitivity to IVIG.Allergol Immunopathol (Madr). 2014 Mar-Apr;42(2):136-41. doi: 10.1016/j.aller.2012.10.006. Epub 2012 Dec 17. Allergol Immunopathol (Madr). 2014. PMID: 23253680
-
Privigen immune globulin intravenous (human), 10% liquid.P T. 2011 Aug;36(8 Section 2):2-31. P T. 2011. PMID: 21935292 Free PMC article. No abstract available.
-
Safety and efficacy of Privigen, a novel 10% liquid immunoglobulin preparation for intravenous use, in patients with primary immunodeficiencies.J Clin Immunol. 2009 Jan;29(1):137-44. doi: 10.1007/s10875-008-9231-2. Epub 2008 Sep 24. J Clin Immunol. 2009. PMID: 18814020 Clinical Trial.
-
Immune globulin (human) 10 % liquid: a review of its use in primary immunodeficiency disorders.BioDrugs. 2013 Aug;27(4):393-400. doi: 10.1007/s40259-013-0044-3. BioDrugs. 2013. PMID: 23703447 Review.
Cited by
-
Comparative Study of Two ELISA Kits for Estimation of Antibodies to Hepatitis B Virus in Human Normal Immunoglobulin and Specific Immunoglobulin Intended for Intravenous or Intramuscular Use.Indian J Clin Biochem. 2017 Jun;32(2):243-245. doi: 10.1007/s12291-016-0590-9. Epub 2016 Jun 29. Indian J Clin Biochem. 2017. PMID: 28428703 Free PMC article.
References
-
- Schiff RI. Treatment of primary immunodeficiency diseases with gammaglobulin. In: Lee ML, Strand V, editors. Intravenous Immunoglobulins in Clinical Practice. New York, NY: Marcel Dekker; 1997. pp. 175–192.
-
- Darabi K, Abdel-Wahab O, Dzik WH. Current usage of intravenous immune globulin and the rationale behind it: The Massachusetts General Hospital data and a review of the literature. Transfusion. 2006;46:741–753. - PubMed
-
- Kazatchkine MD, Kaveri SV. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med. 2001;345:747–755. - PubMed
-
- Orange JS, Hossny EM, Weiler CR, et al. Use of intravenous immunoglobulin in human disease: A review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol. 2006;117:S525–S553. - PubMed
-
- Immune Deficiency Foundation Primary Immune Deficiency Diseases in America: The first national survey of patients and specialistsAvailable at: www.primaryimmune.org/pid/patient_survey_publication.pdf Accessed March 4, 2009.
LinkOut - more resources
Full Text Sources